• About Us
  • Management
  • Board of Directors
  • Corporate Overview
  • Vision/Mission
• Pipeline
  • Proprietary Protein Platform
  • IPLEX
  • Oncology Programs
• Science/Technology
  • People
  • Capabilities
• Newsroom
  • Press Releases
  • Media Inquiries
  • News Subscription
  • Event Calendar
• Investors
  • Stock Info
  • Corporate Governance
  • SEC Filings
  • Stock History
  • Email Alerts
  • Investor Relations
• Careers

Media Inquiries

Please direct media queries to Irma Gomez-Dib - FD at 1-212-850-5761 or via e-mail at: Irma.gomez-dib@fd.com

• Press Releases
• Media Inquiries
• News Subscription
• Event Calendar

Press Releases

• Jun. 30, 2009
  Insmed Announces Addition to the Russell 3000(R) Index Read More
• Jun. 25, 2009
  Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy Read More

• 

• About Us
• Pipeline
• Science/Technology
• Newsroom
• Investors
• Careers

INSMED Incorporated - 8720 Stony Point Parkway - Suite 200 - Richmond, VA 23235
Phone: 804.565.3000Copyright 2008 © All Rights Reserved.